Animal Vaccines Market Size, Share, Trends, Industry Analysis Report: By Type (Livestock and Companion), Product, Disease, Route of Administration, Distribution Channel, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Afr
Description
The animal vaccines market size is expected to reach USD 36.46 billion by 2034, according to a new study by Polaris Market Research. The report “Animal Vaccines Market Size, Share, Trends, Industry Analysis Report: By Type (Livestock and Companion), Product, Disease, Route of Administration, Distribution Channel, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The animal vaccines market involves the development, production, and distribution of vaccines to prevent diseases in livestock, poultry, and companion animals, ensuring animal health, food security, and reducing the risk of zoonotic infections. The animal vaccines market is experiencing significant growth, driven by factors such as the increasing prevalence of zoonotic diseases, rising demand for animal-derived food products, and growing awareness of animal health and welfare. Technological advancements, including the development of recombinant, DNA, and mRNA vaccines, are creating opportunities for more effective and targeted treatments.
The market is also witnessing a shift towards preventive healthcare, with governments implementing stricter vaccination programs to control livestock diseases. Key trends include the rise in pet ownership, the development of combination vaccines, and the expansion of e-commerce platforms for vaccine distribution. The animal vaccines market is poised for continued growth, especially in emerging regions, where improved veterinary infrastructure and greater access to animal healthcare present further opportunities.
Animal Vaccines Market Report Highlights
The livestock segment holds the largest animal vaccines market share due to the high demand for vaccines to prevent diseases in farm animals, while the companion animal segment is registering the fastest growth driven by increasing pet ownership and awareness of pet healthcare.
Attenuated live vaccines dominate the market due to their ability to provide long-lasting immunity with fewer doses. The recombinant vaccines segment is also growing the fastest, driven by innovations in biotechnology and safer vaccine formulations.
Subcutaneous vaccines hold the largest animal vaccines market share due to their ease of administration, while the intranasal route is experiencing the fastest growth due to its non-invasive nature and effectiveness in preventing respiratory diseases.
The hospital/clinic pharmacy segment remains the dominant distribution channel due to the involvement of veterinary professionals in administering vaccines, whereas the e-commerce segment is seeing the fastest growth, driven by increased online sales and home delivery services.
North America holds the largest market share due to its advanced veterinary healthcare infrastructure. Asia Pacific is also experiencing the fastest growth, driven by increasing livestock production and rising awareness of animal health.
Polaris Market Research has segmented animal vaccines market report on the basis of type, product, disease, route of administration, distribution channel, and region:
By Type Outlook (Revenue-USD Billion, 2020–2034)
Livestock
Companion
By Product Outlook (Revenue-USD Billion, 2020–2034)
Attenuated Live Vaccines
Inactivated Vaccines
Subunit Vaccines
DNA Vaccines
Recombinant Vaccines
By Disease (Revenue-USD Billion, 2020–2034)
Swine Pneumonia
Avian Influenza
Rabies
Coccidiosis
Brucellosis
Distemper
Canine
Foot & Mouth
Strangles
By Route of Administration Outlook (Revenue-USD Billion, 2020–2034)
Subcutaneous
Intramuscular
Intranasal
By Distribution Channel Outlook (Revenue-USD Billion, 2020–2034)
Retail
E-Commerce
Hospital/Clinic Pharmacy
By Regional Outlook (Revenue-USD Billion, 2020–2034)
North America
The animal vaccines market involves the development, production, and distribution of vaccines to prevent diseases in livestock, poultry, and companion animals, ensuring animal health, food security, and reducing the risk of zoonotic infections. The animal vaccines market is experiencing significant growth, driven by factors such as the increasing prevalence of zoonotic diseases, rising demand for animal-derived food products, and growing awareness of animal health and welfare. Technological advancements, including the development of recombinant, DNA, and mRNA vaccines, are creating opportunities for more effective and targeted treatments.
The market is also witnessing a shift towards preventive healthcare, with governments implementing stricter vaccination programs to control livestock diseases. Key trends include the rise in pet ownership, the development of combination vaccines, and the expansion of e-commerce platforms for vaccine distribution. The animal vaccines market is poised for continued growth, especially in emerging regions, where improved veterinary infrastructure and greater access to animal healthcare present further opportunities.
Animal Vaccines Market Report Highlights
The livestock segment holds the largest animal vaccines market share due to the high demand for vaccines to prevent diseases in farm animals, while the companion animal segment is registering the fastest growth driven by increasing pet ownership and awareness of pet healthcare.
Attenuated live vaccines dominate the market due to their ability to provide long-lasting immunity with fewer doses. The recombinant vaccines segment is also growing the fastest, driven by innovations in biotechnology and safer vaccine formulations.
Subcutaneous vaccines hold the largest animal vaccines market share due to their ease of administration, while the intranasal route is experiencing the fastest growth due to its non-invasive nature and effectiveness in preventing respiratory diseases.
The hospital/clinic pharmacy segment remains the dominant distribution channel due to the involvement of veterinary professionals in administering vaccines, whereas the e-commerce segment is seeing the fastest growth, driven by increased online sales and home delivery services.
North America holds the largest market share due to its advanced veterinary healthcare infrastructure. Asia Pacific is also experiencing the fastest growth, driven by increasing livestock production and rising awareness of animal health.
Polaris Market Research has segmented animal vaccines market report on the basis of type, product, disease, route of administration, distribution channel, and region:
By Type Outlook (Revenue-USD Billion, 2020–2034)
Livestock
Companion
By Product Outlook (Revenue-USD Billion, 2020–2034)
Attenuated Live Vaccines
Inactivated Vaccines
Subunit Vaccines
DNA Vaccines
Recombinant Vaccines
By Disease (Revenue-USD Billion, 2020–2034)
Swine Pneumonia
Avian Influenza
Rabies
Coccidiosis
Brucellosis
Distemper
Canine
Foot & Mouth
Strangles
By Route of Administration Outlook (Revenue-USD Billion, 2020–2034)
Subcutaneous
Intramuscular
Intranasal
By Distribution Channel Outlook (Revenue-USD Billion, 2020–2034)
Retail
E-Commerce
Hospital/Clinic Pharmacy
By Regional Outlook (Revenue-USD Billion, 2020–2034)
North America
- US
- Canada
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
116 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. Global Animal Vaccines Market Insights
- 4.1. Animal Vaccines Market – Frequency Snapshot
- 4.2. Animal Vaccines Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Prevalence of Zoonotic Diseases
- 4.2.1.2. Growing Demand for Animal-Derived Food Products
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Cost of Vaccines
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Animal Vaccines Market Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
- 5. Global Animal Vaccines Market, by Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Animal Vaccines Market, by Type, 2020-2034 (USD Billion)
- 5.3. Livestock
- 5.3.1. Global Animal Vaccines Market, Livestock, by Region, 2020-2034 (USD Billion)
- 5.4. Companion
- 5.4.1. Global Animal Vaccines Market, by Companion, by Region, 2020-2034 (USD Billion)
- 6. Global Animal Vaccines Market, by Product
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Animal Vaccines Market, by Product, 2020-2034 (USD Billion)
- 6.3. Attenuated Live Vaccines
- 6.3.1. Global Animal Vaccines Market, by Attenuated Live Vaccines, by Region, 2020-2034 (USD Billion)
- 6.4. Inactivated Vaccines
- 6.4.1. Global Animal Vaccines Market, by Inactivated Vaccines, by Region, 2020-2034 (USD Billion)
- 6.5. Subunit Vaccines
- 6.5.1. Global Animal Vaccines Market, by Subunit Vaccines, by Region, 2020-2034 (USD Billion)
- 6.6. DNA Vaccines
- 6.6.1. Global Animal Vaccines Market, by DNA Vaccines, by Region, 2020-2034 (USD Billion)
- 6.7. Recombinant Vaccines
- 6.7.1. Global Animal Vaccines Market, by Recombinant Vaccines, by Region, 2020-2034 (USD Billion)
- 7. Global Animal Vaccines Market, by Disease
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Animal Vaccines Market, by Disease, 2020-2034 (USD Billion)
- 7.3. Swine Pneumonia
- 7.3.1. Global Animal Vaccines Market, by Swine Pneumonia, by Region, 2020-2034 (USD Billion)
- 7.4. Avian Influenza
- 7.4.1. Global Animal Vaccines Market, Avian Influenza, by Region, 2020-2034 (USD Billion)
- 7.5. Rabies
- 7.5.1. Global Animal Vaccines Market, Rabies, by Region, 2020-2034 (USD Billion)
- 7.6. Coccidiosis
- 7.6.1. Global Animal Vaccines Market, Coccidiosis, by Region, 2020-2034 (USD Billion)
- 7.7. Brucellosis
- 7.7.1. Global Animal Vaccines Market, Brucellosis, by Region, 2020-2034 (USD Billion)
- 7.8. Distemper
- 7.8.1. Global Animal Vaccines Market, Distemper, by Region, 2020-2034 (USD Billion)
- 7.9. Canine
- 7.9.1. Global Animal Vaccines Market, Canine, by Region, 2020-2034 (USD Billion)
- 7.10. Foot & Mouth
- 7.10.1. Global Animal Vaccines Market, Foot & Mouth, by Region, 2020-2034 (USD Billion)
- 7.11. Strangles
- 7.11.1. Global Animal Vaccines Market, Strangles, by Region, 2020-2034 (USD Billion)
- 8. Global Animal Vaccines Market, by Route of Administration
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Animal Vaccines Market, by Route of Administration, 2020-2034 (USD Billion)
- 8.3. Subcutaneous
- 8.3.1. Global Animal Vaccines Market, by Subcutaneous, by Region, 2020-2034 (USD Billion)
- 8.4. Intramuscular
- 8.4.1. Global Animal Vaccines Market, by Intramuscular, by Region, 2020-2034 (USD Billion)
- 8.5. Intranasal
- 8.5.1. Global Animal Vaccines Market, by Intranasal, by Region, 2020-2034 (USD Billion)
- 9. Global Animal Vaccines Market, by Distribution Channel
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Global Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 9.3. E-Commerce
- 9.3.1. Global Animal Vaccines Market, by E-Commerce, by Region, 2020-2034 (USD Billion)
- 9.4. Hospital/Clinic Pharmacy
- 9.4.1. Global Animal Vaccines Market, by Hospital/Clinic Pharmacy, by Region, 2020-2034 (USD Billion)
- 9.5. Others
- 9.5.1. Global Animal Vaccines Market, by Others, by Region, 2020-2034 (USD Billion)
- 10. Global Animal Vaccines Market, by Geography
- 10.1. Key Findings
- 10.2. Introduction
- 10.2.1. Animal Vaccines Market Assessment, By Geography, 2020-2034 (USD Billion)
- 10.3. Animal Vaccines Market – North America
- 10.3.1. North America: Animal Vaccines Market, by Type, 2020-2034 (USD Billion)
- 10.3.2. North America: Animal Vaccines Market, by Product, 2020-2034 (USD Billion)
- 10.3.3. North America: Animal Vaccines Market, by Disease, 2020-2034 (USD Billion)
- 10.3.4. North America: Animal Vaccines Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.3.5. North America: Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.3.6. North America: XX
- 10.3.7. Animal Vaccines Market – U.S.
- 10.3.7.1. U.S.: Animal Vaccines Market, by Type, 2020-2034 (USD Billion)
- 10.3.7.2. U.S.: Animal Vaccines Market, by Product, 2020-2034 (USD Billion)
- 10.3.7.3. U.S.: Animal Vaccines Market, by Disease, 2020-2034 (USD Billion)
- 10.3.7.4. U.S.: Animal Vaccines Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.3.7.5. U.S.: Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.3.8. Animal Vaccines Market – Canada
- 10.3.8.1. Canada: Animal Vaccines Market, by Type, 2020-2034 (USD Billion)
- 10.3.8.2. Canada: Animal Vaccines Market, by Product, 2020-2034 (USD Billion)
- 10.3.8.3. Canada: Animal Vaccines Market, by Disease, 2020-2034 (USD Billion)
- 10.3.8.4. Canada: Animal Vaccines Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.3.8.5. Canada: Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.4. Animal Vaccines Market – Europe
- 10.4.1. Europe: Animal Vaccines Market, by Type, 2020-2034 (USD Billion)
- 10.4.2. Europe: Animal Vaccines Market, by Product, 2020-2034 (USD Billion)
- 10.4.3. Europe: Animal Vaccines Market, by Disease, 2020-2034 (USD Billion)
- 10.4.4. Europe: Animal Vaccines Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.4.5. Europe: Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.4.6. Animal Vaccines Market – UK
- 10.4.6.1. UK: Animal Vaccines Market, by Type, 2020-2034 (USD Billion)
- 10.4.6.2. UK: Animal Vaccines Market, by Product, 2020-2034 (USD Billion)
- 10.4.6.3. UK: Animal Vaccines Market, by Disease, 2020-2034 (USD Billion)
- 10.4.6.4. UK: Animal Vaccines Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.4.6.5. UK: Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.4.7. Animal Vaccines Market – France
- 10.4.7.1. France: Animal Vaccines Market, by Type, 2020-2034 (USD Billion)
- 10.4.7.2. France: Animal Vaccines Market, by Product, 2020-2034 (USD Billion)
- 10.4.7.3. France: Animal Vaccines Market, by Disease, 2020-2034 (USD Billion)
- 10.4.7.4. France: Animal Vaccines Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.4.7.5. France: Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.4.8. Animal Vaccines Market – Germany
- 10.4.8.1. Germany: Animal Vaccines Market, by Type, 2020-2034 (USD Billion)
- 10.4.8.2. Germany: Animal Vaccines Market, by Product, 2020-2034 (USD Billion)
- 10.4.8.3. Germany: Animal Vaccines Market, by Disease, 2020-2034 (USD Billion)
- 10.4.8.4. Germany: Animal Vaccines Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.4.8.5. Germany: Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.4.9. Animal Vaccines Market – Italy
- 10.4.9.1. Italy: Animal Vaccines Market, by Type, 2020-2034 (USD Billion)
- 10.4.9.2. Italy: Animal Vaccines Market, by Product, 2020-2034 (USD Billion)
- 10.4.9.3. Italy: Animal Vaccines Market, by Disease, 2020-2034 (USD Billion)
- 10.4.9.4. Italy: Animal Vaccines Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.4.9.5. Italy: Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.4.10. Animal Vaccines Market – Spain
- 10.4.10.1. Spain: Animal Vaccines Market, by Type, 2020-2034 (USD Billion)
- 10.4.10.2. Spain: Animal Vaccines Market, by Product, 2020-2034 (USD Billion)
- 10.4.10.3. Spain: Animal Vaccines Market, by Disease, 2020-2034 (USD Billion)
- 10.4.10.4. Spain: Animal Vaccines Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.4.10.5. Spain: Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.4.11. Animal Vaccines Market – Netherlands
- 10.4.11.1. Netherlands: Animal Vaccines Market, by Type, 2020-2034 (USD Billion)
- 10.4.11.2. Netherlands: Animal Vaccines Market, by Product, 2020-2034 (USD Billion)
- 10.4.11.3. Netherlands: Animal Vaccines Market, by Disease, 2020-2034 (USD Billion)
- 10.4.11.4. Netherlands: Animal Vaccines Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.4.11.5. Netherlands: Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.4.12. Animal Vaccines Market – Russia
- 10.4.12.1. Russia: Animal Vaccines Market, by Type, 2020-2034 (USD Billion)
- 10.4.12.2. Russia: Animal Vaccines Market, by Product, 2020-2034 (USD Billion)
- 10.4.12.3. Russia: Animal Vaccines Market, by Disease, 2020-2034 (USD Billion)
- 10.4.12.4. Russia: Animal Vaccines Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.4.12.5. Russia: Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.4.13. Animal Vaccines Market – Rest of Europe
- 10.4.13.1. Rest of Europe: Animal Vaccines Market, by Type, 2020-2034 (USD Billion)
- 10.4.13.2. Rest of Europe: Animal Vaccines Market, by Product, 2020-2034 (USD Billion)
- 10.4.13.3. Rest of Europe: Animal Vaccines Market, by Disease, 2020-2034 (USD Billion)
- 10.4.13.4. Rest of Europe: Animal Vaccines Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.4.13.5. Rest of Europe: Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.5. Animal Vaccines Market – Asia Pacific
- 10.5.1. Asia Pacific: Animal Vaccines Market, by Type, 2020-2034 (USD Billion)
- 10.5.2. Asia Pacific: Animal Vaccines Market, by Product, 2020-2034 (USD Billion)
- 10.5.3. Asia Pacific: Animal Vaccines Market, by Disease, 2020-2034 (USD Billion)
- 10.5.4. Asia Pacific: Animal Vaccines Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.5.5. Asia Pacific: Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.5.6. Animal Vaccines Market – China
- 10.5.6.1. China: Animal Vaccines Market, by Type, 2020-2034 (USD Billion)
- 10.5.6.2. China: Animal Vaccines Market, by Product, 2020-2034 (USD Billion)
- 10.5.6.3. China: Animal Vaccines Market, by Disease, 2020-2034 (USD Billion)
- 10.5.6.4. China: Animal Vaccines Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.5.6.5. China: Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.5.7. Animal Vaccines Market – India
- 10.5.7.1. India: Animal Vaccines Market, by Type, 2020-2034 (USD Billion)
- 10.5.7.2. India: Animal Vaccines Market, by Product, 2020-2034 (USD Billion)
- 10.5.7.3. India: Animal Vaccines Market, by Disease, 2020-2034 (USD Billion)
- 10.5.7.4. India: Animal Vaccines Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.5.7.5. India: Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.5.8. Animal Vaccines Market – Malaysia
- 10.5.8.1. Malaysia: Animal Vaccines Market, by Type, 2020-2034 (USD Billion)
- 10.5.8.2. Malaysia: Animal Vaccines Market, by Product, 2020-2034 (USD Billion)
- 10.5.8.3. Malaysia: Animal Vaccines Market, by Disease, 2020-2034 (USD Billion)
- 10.5.8.4. Malaysia: Animal Vaccines Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.5.8.5. Malaysia: Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.5.9. Animal Vaccines Market – Japan
- 10.5.9.1. Japan: Animal Vaccines Market, by Type, 2020-2034 (USD Billion)
- 10.5.9.2. Japan: Animal Vaccines Market, by Product, 2020-2034 (USD Billion)
- 10.5.9.3. Japan: Animal Vaccines Market, by Disease, 2020-2034 (USD Billion)
- 10.5.9.4. Japan: Animal Vaccines Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.5.9.5. Japan: Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.5.10. Animal Vaccines Market – Indonesia
- 10.5.10.1. Indonesia: Animal Vaccines Market, by Type, 2020-2034 (USD Billion)
- 10.5.10.2. Indonesia: Animal Vaccines Market, by Product, 2020-2034 (USD Billion)
- 10.5.10.3. Indonesia: Animal Vaccines Market, by Disease, 2020-2034 (USD Billion)
- 10.5.10.4. Indonesia: Animal Vaccines Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.5.10.5. Indonesia: Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.5.11. Animal Vaccines Market – South Korea
- 10.5.11.1. South Korea: Animal Vaccines Market, by Type, 2020-2034 (USD Billion)
- 10.5.11.2. South Korea: Animal Vaccines Market, by Product, 2020-2034 (USD Billion)
- 10.5.11.3. South Korea: Animal Vaccines Market, by Disease, 2020-2034 (USD Billion)
- 10.5.11.4. South Korea: Animal Vaccines Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.5.11.5. South Korea: Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.5.12. Animal Vaccines Market – Australia
- 10.5.12.1. Australia: Animal Vaccines Market, by Type, 2020-2034 (USD Billion)
- 10.5.12.2. Australia: Animal Vaccines Market, by Product, 2020-2034 (USD Billion)
- 10.5.12.3. Australia: Animal Vaccines Market, by Disease, 2020-2034 (USD Billion)
- 10.5.12.4. Australia: Animal Vaccines Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.5.12.5. Australia: Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.5.13. Animal Vaccines Market – Rest of Asia Pacific
- 10.5.13.1. Rest of Asia Pacific: Animal Vaccines Market, by Type, 2020-2034 (USD Billion)
- 10.5.13.2. Rest of Asia Pacific: Animal Vaccines Market, by Product, 2020-2034 (USD Billion)
- 10.5.13.3. Rest of Asia Pacific: Animal Vaccines Market, by Disease, 2020-2034 (USD Billion)
- 10.5.13.4. Rest of Asia Pacific: Animal Vaccines Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.5.13.5. Rest of Asia Pacific: Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.6. Animal Vaccines Market – Middle East & Africa
- 10.6.1. Middle East & Africa: Animal Vaccines Market, by Type, 2020-2034 (USD Billion)
- 10.6.2. Middle East & Africa: Animal Vaccines Market, by Product, 2020-2034 (USD Billion)
- 10.6.3. Middle East & Africa: Animal Vaccines Market, by Disease, 2020-2034 (USD Billion)
- 10.6.4. Middle East & Africa: Animal Vaccines Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.6.5. Middle East & Africa: Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.6.6. Animal Vaccines Market – Saudi Arabia
- 10.6.6.1. Saudi Arabia: Animal Vaccines Market, by Type, 2020-2034 (USD Billion)
- 10.6.6.2. Saudi Arabia: Animal Vaccines Market, by Product, 2020-2034 (USD Billion)
- 10.6.6.3. Saudi Arabia: Animal Vaccines Market, by Disease, 2020-2034 (USD Billion)
- 10.6.6.4. Saudi Arabia: Animal Vaccines Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.6.6.5. Saudi Arabia: Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.6.7. Animal Vaccines Market – UAE
- 10.6.7.1. UAE: Animal Vaccines Market, by Type, 2020-2034 (USD Billion)
- 10.6.7.2. UAE: Animal Vaccines Market, by Product, 2020-2034 (USD Billion)
- 10.6.7.3. UAE: Animal Vaccines Market, by Disease, 2020-2034 (USD Billion)
- 10.6.7.4. UAE: Animal Vaccines Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.6.7.5. UAE: Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.6.8. Animal Vaccines Market – Israel
- 10.6.8.1. Israel: Animal Vaccines Market, by Type, 2020-2034 (USD Billion)
- 10.6.8.2. Israel: Animal Vaccines Market, by Product, 2020-2034 (USD Billion)
- 10.6.8.3. Israel: Animal Vaccines Market, by Disease, 2020-2034 (USD Billion)
- 10.6.8.4. Israel: Animal Vaccines Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.6.8.5. Israel: Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.6.9. Animal Vaccines Market – South Africa
- 10.6.9.1. South Africa: Animal Vaccines Market, by Type, 2020-2034 (USD Billion)
- 10.6.9.2. South Africa: Animal Vaccines Market, by Product, 2020-2034 (USD Billion)
- 10.6.9.3. South Africa: Animal Vaccines Market, by Disease, 2020-2034 (USD Billion)
- 10.6.9.4. South Africa: Animal Vaccines Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.6.9.5. South Africa: Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.6.10. Animal Vaccines Market – Rest of Middle East & Africa
- 10.6.10.1. Rest of Middle East & Africa: Animal Vaccines Market, by Type, 2020-2034 (USD Billion)
- 10.6.10.2. Rest of Middle East & Africa: Animal Vaccines Market, by Product, 2020-2034 (USD Billion)
- 10.6.10.3. Rest of Middle East & Africa: Animal Vaccines Market, by Disease, 2020-2034 (USD Billion)
- 10.6.10.4. Rest of Middle East & Africa: Animal Vaccines Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.6.10.5. Rest of Middle East & Africa: Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.7. Animal Vaccines Market – Latin America
- 10.7.1. Latin America: Animal Vaccines Market, by Type, 2020-2034 (USD Billion)
- 10.7.2. Latin America: Animal Vaccines Market, by Product, 2020-2034 (USD Billion)
- 10.7.3. Latin America: Animal Vaccines Market, by Disease, 2020-2034 (USD Billion)
- 10.7.4. Latin America: Animal Vaccines Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.7.5. Latin America: Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.7.6. Animal Vaccines Market – Mexico
- 10.7.6.1. Mexico: Animal Vaccines Market, by Type, 2020-2034 (USD Billion)
- 10.7.6.2. Mexico: Animal Vaccines Market, by Product, 2020-2034 (USD Billion)
- 10.7.6.3. Mexico: Animal Vaccines Market, by Disease, 2020-2034 (USD Billion)
- 10.7.6.4. Mexico: Animal Vaccines Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.7.6.5. Mexico: Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.7.7. Animal Vaccines Market – Brazil
- 10.7.7.1. Brazil: Animal Vaccines Market, by Type, 2020-2034 (USD Billion)
- 10.7.7.2. Brazil: Animal Vaccines Market, by Product, 2020-2034 (USD Billion)
- 10.7.7.3. Brazil: Animal Vaccines Market, by Disease, 2020-2034 (USD Billion)
- 10.7.7.4. Brazil: Animal Vaccines Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.7.7.5. Brazil: Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.7.8. Animal Vaccines Market – Argentina
- 10.7.8.1. Argentina: Animal Vaccines Market, by Type, 2020-2034 (USD Billion)
- 10.7.8.2. Argentina: Animal Vaccines Market, by Product, 2020-2034 (USD Billion)
- 10.7.8.3. Argentina: Animal Vaccines Market, by Disease, 2020-2034 (USD Billion)
- 10.7.8.4. Argentina: Animal Vaccines Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.7.8.5. Argentina: Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 10.7.9. Animal Vaccines Market – Rest of Latin America
- 10.7.9.1. Rest of Latin America: Animal Vaccines Market, by Type, 2020-2034 (USD Billion)
- 10.7.9.2. Rest of Latin America: Animal Vaccines Market, by Product, 2020-2034 (USD Billion)
- 10.7.9.3. Rest of Latin America: Animal Vaccines Market, by Disease, 2020-2034 (USD Billion)
- 10.7.9.4. Rest of Latin America: Animal Vaccines Market, by Route of Administration, 2020-2034 (USD Billion)
- 10.7.9.5. Rest of Latin America: Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 11. Competitive Landscape
- 11.1. Expansion and Acquisition Analysis
- 11.1.1. Expansion
- 11.1.2. Acquisitions
- 11.2. Partnerships/Collaborations/Agreements/Exhibitions
- 12. Company Profiles
- 12.1. Zoetis Inc.
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Benchmarking
- 12.1.4. Recent Development
- 12.2. Merck & Co., Inc. (Merck Animal Health)
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Benchmarking
- 12.2.4. Recent Development
- 12.3. Boehringer Ingelheim International GmbH
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Benchmarking
- 12.3.4. Recent Development
- 12.4. Elanco Animal Health Incorporated
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Benchmarking
- 12.4.4. Recent Development
- 12.5. Ceva Santé Animale
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Benchmarking
- 12.5.4. Recent Development
- 12.6. Virbac
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Benchmarking
- 12.6.4. Recent Development
- 12.7. Phibro Animal Health Corporation
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Benchmarking
- 12.7.4. Recent Development
- 12.8. HIPRA
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Benchmarking
- 12.8.4. Recent Development
- 12.9. Dechra Pharmaceuticals PLC
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Benchmarking
- 12.9.4. Recent Development
- 12.10. Vetoquinol S.A.
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Benchmarking
- 12.10.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
